Jake Kraft
Jake Kraft is Co-founder and Chief Executive Officer at Lila Bio. He was Acting Instructor and Translational Investigator at the Institute for Protein Design, University of Washington, and Founder at Qualtonomy.
Jake Kraft announces Lila Bio wins $3.65M NIH SBIR Fast-Track from NHLBI to develop long‑acting AI-designed PH therapies
Lila Bio won a $3.65M NIH SBIR Fast-Track award from NHLBI to develop AI-designed, long-acting injectable mono- and multi-specific protein therapies for pulmonary hypertension, aiming for disease-modifying effects with dosing every 2–4 times per year.
Organizations
See all 8-
Lila Bio CEO & Co-Founder 2023–present · current
-
Institute for Protein Design, University of Washington Acting Instructor, Translational Investigator 2023, Translational Postdoc 2022–2023, Senior Postdoctoral Fellow 2018–2022 · past
-
University of Washington Pharmaceutics PhD Student 2013–2018, Research Scientist 2013, Book Editor 2012–2013, Research Study Assistant 2008–2011 · past
Education
-
University of Washington Doctor of Philosophy - PhD, Pharmaceutics · 2013–2018
-
The University of Kansas BS, Chemistry · 2004–2007
-
Institute for American Universities (IAU) French · 2004
-
University of San Diego 2002–2004